Jim Hoffman: Affinity-Based Blood Purification as a Potential Alternative to Plasma Exchange
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
“A business model for improved therapeutic extracorporeal blood purification methods to follow that are capable of depleting toxic levels of extracellular chromatin from the blood.
These newer affinity-based methods , which effectively deplete extracellular chromatin and allow patients to keep their own blood with greatly reduced toxic levels of extracellular chromatin, should be evaluated as a replacement for more expensive and likely less effective Therapeutic Plasma Exchange (TPE).
This could greatly increase badly needed affordable access to treatment and potentially prevent and treat chronic illness disease progression more efficaciously than TPE.
A small sampling of the research implicating elevated extracellular chromatin contributing to multi-organ injury and disease progression:”
Find more posts featuring Jim Hoffman on Hemostasis Today.
-
Apr 2, 2026, 18:16Saravanan Subramaniam: How Extracellular Histones Act as Key Drivers of Thromboinflammation
-
Apr 2, 2026, 18:06Rob Molhoek Brings Invaluable Insights on Stroke Awareness and Care Improvements – Stroke Foundation
-
Apr 2, 2026, 17:21Paul Bolaji: Phase 2 of the Nigeria National Stroke Registry Is Now Live
-
Apr 2, 2026, 17:13Catherine Jennings: Marking Today as an Important Step Forward for Patients With PE
-
Apr 2, 2026, 17:11Arun V. J: Our Clinical Audit on Transfusion Safety Selected for Presentation at CAHOCON 2026
-
Apr 2, 2026, 17:10Maxime Dely: Better Collection, Better Blood – The Quality Starts Now
-
Apr 2, 2026, 17:09Arun Danewa: Saving a Bone Marrow Patient from Hidden Enemy – TA-TMA
-
Apr 2, 2026, 17:07Cathy Harrison: The WFH Nurses Committee are Looking for New Members
-
Apr 2, 2026, 16:30Sam K. Saha: The Hardest Cases Are the Ones You Can’t Save